CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
This section explains the timing rules for withdrawing Backdoor Roth contributions and how distribution order can affect taxes and penalties.
27,795 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Apple’s shares tumbled after WWDC-style AI updates raised questions about iPhone upgrades and monetization. This guid...
The relationship between OpenAI and Microsoft once looked like a straightforward path to AI profits. Today, smart mon...
A stock split made shares cheaper, but the real driver of Amazon’s rally is its expanding AI and cloud empire. Here’s...
Investing in biotech can be bold. This piece lays out practical scenarios for what much could $1,000 invested in Viki...
The monthly nonfarm payrolls report is a big market event, but it can mislead if you lean on it without guarding agai...
Climate risk scores are moving from a niche risk tool to a gatekeeper in many loan deals. This article breaks down wh...
Oil has moved markets again, with crude flirting with triple digits and energy stocks lighting up in response. This g...
Peloton has faced a brutal selloff, but the story isn’t finished. This article dives into whether Peloton is broken o...
As the clean energy shift accelerates, two hydrogen-focused leaders—Bloom Energy and Plug Power—offer distinct paths ...
If you’re looking for a steadier way to grow wealth over the long term, bank stock can be part of the answer. This gu...
SpaceX aims to put AI compute in orbit by 2028, a move that could reshape data centers. This article breaks down the ...